LAVVAN is focused on the production of high-quality and reliably sourced cannabinoids for a range of end markets.
In collaboration with Amyris, LAVVAN is developing fermentation based technology to unlock the full potential of the cannabinoid family of molecules.
LAVVAN is backed by leaders across the cannabis, food and beverage, and pharmaceutical industries.
Dr. Jeremy N. Friedberg
Chief Science Officer
SVP, Regulatory Affairs & Quality Assurance
Senior Advisor, Product Strategy
Director, Product Development
Director, Process Sciences
Strategic Advisory Board
Managing Partner at GrowthWay Partners
Group President, Luxe Division, L'Oréal
Founder at The 100 Mile Group
Investor at CGC Ventures
Non-Executive Chairman at VMLY&R
Former CEO of Saks Inc.